Lemonade price target raised to $80 from $60 at Citizens JMP

Citizens JMP analyst Matthew Carletti raised the firm’s price target on Lemonade (LMND) to $80 from $60 and keeps an Outperform rating on the shares. Lemonade remains very early in its life cycle and is making significant strides toward building an insurance company that will continue to gain market share and sustain the test of time, the analyst tells investors in a research note.